International variations in bladder cancer incidence and mortality.
about
High-Risk Non-Muscle-Invasive Bladder Cancer-Therapy Options During Intravesical BCG ShortageAssociation between Perioperative Blood Transfusions and Clinical Outcomes in Patients Undergoing Bladder Cancer Surgery: A Systematic Review and Meta-Analysis StudyUrological malignancy in Hong Kong: the trend and the practiceModifiable risk factors for the prevention of bladder cancer: a systematic review of meta-analysesIncidence of kidney, bladder, and prostate cancers in Korea: An updateThe contemporary landscape of occupational bladder cancer within the United Kingdom: a meta-analysis of risks over the last 80 years.A nomogram predicting the cancer-specific mortality in patients eligible for radical cystectomy evaluating clinical data and neoadjuvant cisplatinum-based chemotherapy.Pioglitazone utilization, efficacy & safety in Indian type 2 diabetic patients: A systematic review & comparison with European Medicines Agency Assessment Report.Increased lncRNA ABHD11-AS1 represses the malignant phenotypes of bladder cancerOpium and bladder cancer: A systematic review and meta-analysis of the odds ratios for opium use and the risk of bladder cancer.The gender difference and mortality-to-incidence ratio relate to health care disparities in bladder cancer: National estimates from 33 countriesThe patients' experience of a bladder cancer diagnosis: a systematic review of the qualitative evidenceMicroRNA-99a and 100 mediated upregulation of FOXA1 in bladder cancer.Fruits, vegetables, and bladder cancer risk: a systematic review and meta-analysis.Long noncoding RNA GHET1 promotes the development of bladder cancerSEOM clinical guidelines for the treatment of renal cell carcinoma.Artificial urinary conduit construction using tissue engineering methods.Trends in the Use of Chemotherapy before and after Radical Cystectomy in Patients with Muscle-invasive Bladder Cancer in Korea.Early diagnosis of bladder cancer through the detection of urinary tyrosine-phosphorylated proteins.An uncommon manifestation of paraneoplastic cerebellar degeneration in a patient with high grade urothelial, carcinoma with squamous differentiation: A case report and literature reviewIncidence and Survival of urothelial carcinoma of the urinary bladder in Norway 1981-2014.Clinical Practice Pattern of Immediate Intravesical Chemotherapy following Transurethral Resection of a Bladder Tumor in Korea: National Health Insurance Database StudyNovel variants in MLL confer to bladder cancer recurrence identified by whole-exome sequencing.Management of T1 Urothelial Carcinoma of the Bladder: What Do We Know and What Do We Need To Know?Mucinous adenocarcinoma of the bladder: A case report and review of the literature.Tea Consumption and Risk of Bladder Cancer: A Dose-Response Meta-AnalysisAltered RECQL5 expression in urothelial bladder carcinoma increases cellular proliferation and makes RECQL5 helicase activity a novel target for chemotherapy.Positive association of collagen type I with non-muscle invasive bladder cancer progression.ATM participates in the regulation of viability and cell cycle via ellipticine in bladder cancer.Down-regulation of LncRNA TUG1 enhances radiosensitivity in bladder cancer via suppressing HMGB1 expression.Fibrous sheath interacting protein 1 overexpression is associated with unfavorable prognosis in bladder cancer: a potential therapeutic target.MicroRNA expression profiling in bladder cancer: the challenge of next-generation sequencing in tissues and biofluids.Chemotherapy for Muscle-Invasive Bladder Cancer.Overexpression of long non-coding RNA TUG1 predicts poor prognosis and promotes cancer cell proliferation and migration in high-grade muscle-invasive bladder cancer.Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: A Systematic Review and Two-Step Meta-Analysis.Double-negative feedback loop between long non-coding RNA TUG1 and miR-145 promotes epithelial to mesenchymal transition and radioresistance in human bladder cancer cells.An evaluation of morphological and functional multi-parametric MRI sequences in classifying non-muscle and muscle invasive bladder cancer.What is new in non-muscle-invasive bladder cancer in 2016?Impact of smoking status and cumulative smoking exposure on tumor recurrence of non-muscle-invasive bladder cancer.Opa interacting protein 5 acts as an oncogene in bladder cancer.
P2860
Q26739003-BFA36ECB-ABF3-4005-83FD-02DD08FEBCF7Q26768275-2F5F5F95-564B-4EC5-861B-D3D3CC555917Q26785709-BC268B46-1122-4C44-A994-189CDB34E356Q28072392-AB457B81-5B27-4872-BC88-B6BF38071115Q28082161-78A62CEE-6CFD-40FC-9578-AB872DC5A05AQ30249425-AC65E6CD-DCFE-49A9-BDCC-E4F2304D0E36Q30981992-B9DD72A3-AA33-4DAF-9DB5-036E0101530FQ33568852-75094961-A0E8-4663-9BF3-7BD24E3D2C8EQ33709621-DDA6475D-F600-402F-8DF6-6095194EEF33Q33769123-C2D94488-B7DE-4812-BD1A-A7E43FF7EB81Q33849247-729B2CA4-F593-4842-BA33-F0E660B20448Q33881954-33C0A630-5772-4C49-8040-FD55A29D3BD9Q34227727-C02AA0D2-316F-4095-AA45-22F820D48178Q34451354-634F6147-40A8-4CB9-BBE0-CD12A110665DQ34501968-4C31FE93-B805-45A7-BCE4-11A3E002C4E1Q34553411-2043BF26-C728-4A7E-B115-C83C8B8DF6D8Q35533831-3FEE13A3-CD2A-49C2-8625-110107210B13Q35905142-BA950545-E376-4D2E-B876-E2CAE9D59540Q35909661-8DE62220-73C7-471F-B4D9-8CBB39645868Q36025469-F82F9295-3C7B-42BD-8139-045B986DF6CCQ36163111-574108CE-F18D-4FF8-9191-769EABB75F8AQ36687904-A7C36A8C-E9D2-42B7-BCDE-145ADF8B364FQ36771895-7AEA79CE-249C-4F56-A831-A0D0E6F34A91Q37053829-462EEB1B-C1E8-4834-805A-C6809CB13F37Q37289505-345CD588-C712-4044-A601-8C52580EA38FQ37597871-E575A267-B591-428D-A323-1D241D361147Q37689080-6E53A72B-F819-42D5-BB38-5F7259D0E1A8Q37696186-C232E6B6-6EEE-4BAB-8D88-22C147693F53Q37722144-92ECFC91-28B6-43BB-B96D-C575AF3FC6A9Q37737916-D65F59F0-1F05-4D2C-956C-A74E4B768AF0Q38598956-F6A0D434-50F1-4596-8105-38E6F13D6628Q38613417-0822046A-5AB8-40C1-8CA9-CD9D892C4E24Q38711504-DD491732-79F7-4B9C-A0AE-3A19693CDA58Q38755660-31DBF8DB-C01C-4B65-85DF-E737D03795FDQ38800274-2E05F324-4D66-40EF-9893-3796E3A94D38Q38839771-518B32E2-AB13-4C6B-BEBA-21AAEE53C6D3Q38970633-4E7A11B4-2B83-49E0-8D3E-F7B33F4427FBQ39167317-B9AE2762-8CE2-4A75-A25F-05D481094287Q39264174-F6A54FE4-4D11-4970-9A93-82B9F31F0C5AQ40116026-80A4A373-AF4C-42D0-95F3-AE87E80BF6D7
P2860
International variations in bladder cancer incidence and mortality.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
International variations in bladder cancer incidence and mortality.
@en
type
label
International variations in bladder cancer incidence and mortality.
@en
prefLabel
International variations in bladder cancer incidence and mortality.
@en
P2093
P1433
P1476
International variations in bladder cancer incidence and mortality
@en
P2093
Ahmedin Jemal
Joannie Lortet-Tieulent
Michael Goodman
P356
10.1016/J.EURURO.2013.10.001
P407
P577
2013-10-16T00:00:00Z